JHOP Articles

Skip to main content

Acute Lymphoblastic Leukemia

Treatment-Associated Neurotoxicity in Patients with Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia

Minimal Residual Disease Testing in Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia

Roles and Responsibilities of the Multidisciplinary Care Team in Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia

Transition of Care for Patients with Acute Lymphoblastic Leukemia

Review Article, CAR T-Cell Therapy

CAR T-Cell Therapy: Review of the Newest Weapon in the Battle Against Hematologic Malignancies

Dennis Marjoncu, PharmD, BCOP

Dennis Marjoncu, PharmD, BCOP

Case Reports, Breast Cancer, Adverse Events

Hypersensitivity Reactions to Taxanes and Subsequent Treatment with Nab-Paclitaxel: Case Reports of 2 Women with Early-Stage Breast Cancer

Kevin Straughn, PharmD, Robin Hardie-Hood, MD, Jordan Carrera, PharmD, BCPS, BCOP

Kevin Straughn, PharmD; Robin Hardie-Hood, MD; Jordan Carrera, PharmD, BCPS, BCOP

FDA Updates

Cytalux, a Novel Imaging Agent, FDA Approved for Diagnosing Inoperable Ovarian Cancer Lesions

FDA Updates

FDA Approved Fyarro for Malignant Perivascular Epithelioid-Cell Tumor

FDA Updates

Oral Scemblix FDA Approved for Patients with Ph-Positive Chronic Myeloid Leukemia

FDA Updates

Darzalex Faspro, Kyprolis, and Dexamethasone a New Combination FDA Approved for Multiple Myeloma

Page 74 of 196
Results 731 - 740 of 1953